Estimating the Lifetime Clinical Risk/Benefits of Apixaban Versus Edoxaban in Non-Valvular Atrial Fibrillation

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.03.762
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pcv84 - Cost-Effectiveness Analysis of Apixaban Versus Edoxaban for Stroke Prevention in Non-Valvular Atrial Fibrillation Spanish Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness of Apixaban for Stroke Prevention in Non-Valvular Atrial Fibrillation in Saudi Arabia

Annals of Saudi Medicine
Medicine
2019English

Effect and Risk of Novel Oral Anticoagulants Versus Warfarin in Patients With Non-Valvular Atrial Fibrillation

Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

The Economic Impact Associated With Cerebrovascular Events Related to Non-Valvular Atrial Fibrillation (NVAF) in Italy: The Role of Apixaban

Farmeconomia. Health economics and therapeutic pathways
2014English

Clinical Characteristics and 12-Month Outcomes of Patients With Valvular and Non-Valvular Atrial Fibrillation in Kenya

PLoS ONE
Multidisciplinary
2017English

Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation

American Journal of Cardiology
Cardiovascular MedicineCardiology
2015English

Pcv116 - Discontinuation and Health Care Resource Utilisation in Non-Valvular Atrial Fibrillation Patients Treated With Apixaban or Warfarin in England

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Thromboembolic Events in Paroxysmal vs. Permanent Non-Valvular Atrial Fibrillation

Circulation Journal
MedicineCardiovascular MedicineCardiology
2014English

Suboptimal Oral Anticoagulant Treatment Among Chinese Non-Valvular Atrial Fibrillation Patients: The Nanchang Atrial Fibrillation Project

Archives of Medical Science
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy